Ying-Dong Li Selected Research

Vaccines

2/2018	Astragalus Saponins and Liposome Constitute an Efficacious Adjuvant Formulation for Cancer Vaccines.
1/2018	A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Dong Li Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 01/2014
2	Neoplasm Metastasis (Metastasis) 02/2018 - 01/2018
1	Heart Failure 10/2020
1	Heart Diseases (Heart Disease) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Liver Neoplasms (Liver Cancer) 09/2014
1	Body Weight (Weight, Body) 08/2014
1	Gastroparesis 08/2014
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2014
1	Fibrosis (Cirrhosis) 01/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2014
2	VaccinesIBA 02/2018 - 01/2018
2	Liposomes (Liposome)IBA 02/2018 - 01/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2018 - 01/2018
2	SaponinsIBA 02/2018 - 01/2018
1	Cancer VaccinesIBA 02/2018
1	AntigensIBA 02/2018
1	AlginatesIBA 01/2018
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2018
1	Radiation-Sensitizing AgentsIBA 09/2014
1	Drinking WaterIBA 08/2014
1	Ethanol (Ethyl Alcohol)IBA 08/2014
1	Blood Glucose (Blood Sugar)IBA 08/2014
1	Therapeutic UsesIBA 08/2014
1	IonsIBA 04/2014
1	DiaminesIBA 01/2014
1	CollagenIBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 01/2014
1	AntioxidantsIBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2014
1	tanshinone II A sodium sulfonateIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014

Therapy/Procedure

1	Exercise Therapy (Therapy, Exercise) 10/2020
1	Radiotherapy 01/2019
1	Therapeutics 02/2018
1	Immunotherapy 01/2018